Latest Boardroom Shifts News

James Hardie Industries has appointed Nigel Stein as the new Chair of its Board and established an Integration and Performance Committee to oversee the AZEK acquisition integration and enhance shareholder engagement.

Dalaroo Metals has appointed seasoned mining executive John Morgan as CEO, signaling a strategic push to advance its exploration projects across multiple continents. His performance-linked incentives align leadership rewards with shareholder value creation.

ALS Limited has reported a robust first half for FY26, with revenue climbing 13.3% to $1.7 billion and underlying NPAT rising 17.2%, driven by strong organic growth across all business streams and strategic investments in digital innovation.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Elders Limited reported a solid FY25 with a 12% rise in profit after tax to $50.3 million, completing the strategic acquisition of Delta Agribusiness and advancing key operational and sustainability initiatives.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Develop Global Limited clarifies its director appointment and retirement process following an ASX compliance query, ensuring adherence to governance rules.

Navigator Global Investments appoints Roger Davis as new Chair and suspends dividends to prioritize capital for growth and new partnerships.